Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...
Hosted on MSN5h
Herbicide under US scrutiny over potential Parkinson's linkFirst came the slow hand movements, then the tremor, and now the looming fear of what lies ahead. By the end of the decade, ...
Hosted on MSN8h
How to Spot the Early Symptoms of Parkinson's DiseaseWhile celebrities like Michael J. Fox and Brett Favre have been open about their struggles with Parkinson's disease, it can ...
Stimulating dopamine-producing brain cells wirelessly with gold nanoparticles has proven effective at treating mice with ...
A 47-year-old man was the first in the world to be treated outside of a study context with a new technique for the symptoms ...
While hearing loss has been associated with cognitive decline and considered a risk factor for dementia, this study, ...
The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify ...
AskBio begins patient randomizing in phase II gene therapy trial for Parkinson’s disease: Berlin, Germany Wednesday, January 15, 2025, 14:00 Hrs [IST] AskBio Inc. (AskBio), a ge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback